Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00306800 · ClinicalTrials.gov registry record · Phase 3
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
A Phase 3 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT00306800 is a Phase 3 study that has completed, run by Galderma R&D. The registered enrollment target is 80 participants.
The verdict
NCT00306800, a Phase 3 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of Photodynamic Therapy (PDT) with methyl aminolevulinate (MAL) cream to PDT with vehicle cream, using the the LED light source Aktilite CL128, in treatment of patients with multiple actinic keratosis (sun-damaged skin) on the face and / or scalp
Interventions
- PROCEDURE Photodynamic therapy with methyl aminolevulinate cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00306800
The ClinicalTrials.gov registry entry for NCT00306800 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Photodynamic therapy with methyl aminolevulinate cream is the first listed.
NCT00306800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00306800 about?
NCT00306800 is a clinical study titled "Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp". The purpose of this study is to compare the efficacy of Photodynamic Therapy (PDT) with methyl aminolevulinate (MAL) cream to PDT with vehicle cream, using the the LED light source Aktilite CL128, in treatment of patients with multiple actinic keratosis (sun-damaged skin) on the face and / or scalp
What is the current status of trial NCT00306800?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2007-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00306800?
The interventions under investigation include: Photodynamic therapy with methyl aminolevulinate cream (PROCEDURE).
Who is sponsoring clinical trial NCT00306800?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.